Literature DB >> 27612986

D-dimer measured at first venous thromboembolism is associated with future risk of cancer.

Olga V Gran1, Sigrid K Brækkan2,3, Benedikte Paulsen2, Hanne Skille2, John-Bjarne Hansen2,3.   

Abstract

Entities:  

Keywords:  D-dimer; cancer; disorders of coagulation and fibrinolysisl; venous thrombosis

Mesh：

Substances：

Year:  2016        PMID： 27612986      PMCID： PMC5479625          DOI： 10.3324/haematol.2016.151712

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  18 in total

1.  The predictive value of D-dimer measurement for cancer in patients with deep vein thrombosis.

Authors:  Roger E G Schutgens; Marielle M J Beckers; Fred J L M Haas; Douwe H Biesma
Journal:  Haematologica       Date:  2005-02       Impact factor: 9.941

2.  The risk of a diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism.

Authors:  H T Sørensen; L Mellemkjaer; F H Steffensen; J H Olsen; G L Nielsen
Journal:  N Engl J Med       Date:  1998-04-23       Impact factor: 91.245

Review 3.  Venous thromboembolism and cancer: a two-way clinical association.

Authors:  P Prandoni; A Piccioli
Journal:  Front Biosci       Date:  1997-04-01

4.  Body height and risk of venous thromboembolism: The Tromsø Study.

Authors:  Sigrid K Braekkan; Knut H Borch; Ellisiv B Mathiesen; Inger Njølstad; Tom Wilsgaard; John-Bjarne Hansen
Journal:  Am J Epidemiol       Date:  2010-04-23       Impact factor: 4.897

5.  Preoperative plasma D-dimer predicts 1-year survival in colorectal cancer patients with absence of venous thromboembolism (VTE): a prospective clinical cohort study.

Authors:  M T Stender; T B Larsen; H T Sørensen; O Thorlacius-Ussing
Journal:  J Thromb Haemost       Date:  2012-10       Impact factor: 5.824

6.  Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis.

Authors:  Philip S Wells; David R Anderson; Marc Rodger; Melissa Forgie; Clive Kearon; Jonathan Dreyer; George Kovacs; Michael Mitchell; Bernard Lewandowski; Michael J Kovacs
Journal:  N Engl J Med       Date:  2003-09-25       Impact factor: 91.245

7.  Hypercoagulabilty, venous thromboembolism, and death in patients with cancer. A Multi-State Model.

Authors:  Florian Posch; Julia Riedl; Eva-Maria Reitter; Alexandra Kaider; Christoph Zielinski; Ingrid Pabinger; Cihan Ay
Journal:  Thromb Haemost       Date:  2016-01-07       Impact factor: 5.249

Review 8.  Role of tissue factor in cancer.

Authors:  Raj S Kasthuri; Mark B Taubman; Nigel Mackman
Journal:  J Clin Oncol       Date:  2009-09-08       Impact factor: 44.544

9.  30-year mortality after venous thromboembolism: a population-based cohort study.

Authors:  Kirstine Kobberøe Søgaard; Morten Schmidt; Lars Pedersen; Erzsébet Horváth-Puhó; Henrik Toft Sørensen
Journal:  Circulation       Date:  2014-06-26       Impact factor: 29.690

10.  Estimating risk of venous thromboembolism in patients with cancer in the presence of competing mortality.

Authors:  C Ay; F Posch; A Kaider; C Zielinski; I Pabinger
Journal:  J Thromb Haemost       Date:  2015-01-14       Impact factor: 5.824
View more
  1 in total

1.  Assessment of cardiac biomarkers (troponin, B-type natriuretic peptide, and D-dimer) in patients with non-valvular atrial fibrillation and stroke.

Authors:  Bilonda K Paulin; Kabulo K Cedric; Abdelhakam G Tamomh; Yang Dong Hui
Journal:  Int J Health Sci (Qassim)       Date:  2019 Nov-Dec
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.